Publication:
Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials

dc.contributor.authorBurckhardt, Bjoern B. (55383006300)
dc.contributor.authorCiplea, Agnes Maria (57203856912)
dc.contributor.authorLaven, Anna (22634866000)
dc.contributor.authorAblonczy, László (36636785400)
dc.contributor.authorKlingmann, Ingrid (6602830730)
dc.contributor.authorLäer, Stephanie (7003476724)
dc.contributor.authorKleine, Karl (57209315896)
dc.contributor.authorDalinghaus, Michiel (6601975474)
dc.contributor.authorĐukić, Milan (56835361300)
dc.contributor.authorBreur, Johannes M. P. J. (6506168146)
dc.contributor.authorvan der Meulen, Marijke (57126909900)
dc.contributor.authorSwoboda, Vanessa (56465046300)
dc.contributor.authorSchwender, Holger (6506833490)
dc.contributor.authorLagler, Florian B. (14061979400)
dc.date.accessioned2025-06-12T13:56:46Z
dc.date.available2025-06-12T13:56:46Z
dc.date.issued2020
dc.description.abstractBackground: Pediatric trials to add missing data for evidence-based pharmacotherapy are still scarce. A tailored training concept appears to be a promising tool to cope with critical and complex situations before enrolling the very first patient and subsequently to ensure high-quality study conduct. The aim was to facilitate study success by optimizing the preparedness of the study staff shift. Method: An interdisciplinary faculty developed a simulation training focusing on the communication within the informed consent procedure and the conduct of the complex pharmacokinetic/pharmacodynamic (PK/PD) sampling within a simulation facility. Scenarios were video-debriefed by an audio-video system and manikins with artificial blood simulating patients were used. The training was evaluated by participants' self-assessment before and during trial recruitment. Results: The simulation training identified different optimization potentials for improved informed consent process and study conduct. It facilitated the reduction of avoidable errors, especially in the early phase of a clinical study. The knowledge gained through the intervention was used to train the study teams, improve the team composition and optimize the on-ward setting for the FP-7 funded “LENA” project (grant agreement no. 602295). Self-perceived ability to communicate core elements of the trial as well as its correct performance of sample preparation increased significantly (mean, 95% CI, p ≤ 0.0001) from 3 (2.5–3.5) to four points (4.0–4.5), and from 2 (1.5–2.5) to five points (4.0–5.0). Conclusion: An innovative training concept to optimize the informed consent process and study conduct was successfully developed and enabled high-quality conduct of the pediatric trials as of the very first patient visit. © Copyright © 2020 Burckhardt, Ciplea, Laven, Ablonczy, Klingmann, Läer, Kleine, Dalinghaus, Đukić, Breur, van der Meulen, Swoboda, Schwender and Lagler.
dc.identifier.urihttps://doi.org/10.3389/fphar.2020.603042
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85098274420&doi=10.3389%2ffphar.2020.603042&partnerID=40&md5=845a0c74e4ba06eaac8c28d6e07f5302
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/4617
dc.subjectclinical study
dc.subjectcommunication
dc.subjectpatient recruitment
dc.subjectpediatrics
dc.subjectpharmacokinetic/pharmacodynamic
dc.subjectsimulation training
dc.subjectstudy conduct
dc.titleSimulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials
dspace.entity.typePublication

Files